{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:42:39Z","timestamp":1789123359556,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA217674"],"award-info":[{"award-number":["P50 CA217674"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.gassur.2025.102275","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:45:49Z","timestamp":1762285549000},"page":"102275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7691-0170","authenticated-orcid":false,"given":"Joe","family":"Eid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Shin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wei D.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hop S.","family":"Tran Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Kaseb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gassur.2025.102275_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","article-title":"Current epidemiology in hepatocellular carcinoma","volume":"15","author":"Konyn","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gassur.2025.102275_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"issue":"30","key":"10.1016\/j.gassur.2025.102275_bib3","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.3748\/wjg.v20.i30.10249","article-title":"Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102275_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2050-7771-1-10","article-title":"Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy","volume":"1","author":"Zhu","year":"2013","journal-title":"Biomark Res"},{"issue":"5","key":"10.1016\/j.gassur.2025.102275_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.gassur.2025.102275_bib6","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3390\/cancers16122183","article-title":"Emerging prognostic markers in patients undergoing liver resection for hepatocellular carcinoma: a narrative review","volume":"16","author":"Panettieri","year":"2024","journal-title":"Cancers"},{"issue":"37","key":"10.1016\/j.gassur.2025.102275_bib7","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.3748\/wjg.v24.i37.4230","article-title":"New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma","volume":"24","author":"Lorente","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gassur.2025.102275_bib8","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/cncr.11839","article-title":"The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma","volume":"98","author":"Nagaoka","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2025.102275_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2407-14-104","article-title":"Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis","volume":"14","author":"Xiao","year":"2014","journal-title":"BMC Cancer"},{"issue":"35","key":"10.1016\/j.gassur.2025.102275_bib10","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.3748\/wjg.v24.i35.3974","article-title":"Biomarkers for hepatocellular carcinoma: what\u2019s new on the horizon?","volume":"24","author":"Ocker","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gassur.2025.102275_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737159.2021.1987217","article-title":"Predictive biomarkers for systemic therapy of hepatocellular carcinoma","volume":"21","author":"Moldogazieva","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"10.1016\/j.gassur.2025.102275_bib12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment","volume":"9","author":"Pi\u00f1ero","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.gassur.2025.102275_bib13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms19051308","article-title":"Insulin-like growth factor (IGF) system in liver diseases","volume":"19","author":"Adamek","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gassur.2025.102275_bib14","first-page":"131","article-title":"Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma","volume":"2","author":"Abdel-Wahab","year":"2015","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.gassur.2025.102275_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000090640","article-title":"Overview of the IGF-I system","volume":"65","author":"Cohen","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.gassur.2025.102275_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fncel.2017.00014","article-title":"Insulin-like growth factor 1: at the crossroads of brain development and aging","volume":"11","author":"Wrigley","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.gassur.2025.102275_bib17","first-page":"77","article-title":"Role of insulin-like growth factor iin maintaining normal glucose homeostasis","volume":"62","author":"Clemmons","year":"2004","journal-title":"Horm Res"},{"key":"10.1016\/j.gassur.2025.102275_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1479-5876-10-224","article-title":"Human conditions of insulin-like growth factor-I (IGF-I) deficiency","volume":"10","author":"Puche","year":"2012","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.gassur.2025.102275_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2010.02428.x","article-title":"Insulin-like growth factor-I and the liver","volume":"31","author":"Bonefeld","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.gassur.2025.102275_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7314\/APJCP.2015.16.2.613","article-title":"Predictive value of serum insulin-like growth factor-1 in hepatocellular carcinoma","volume":"16","author":"Elmashad","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"29","key":"10.1016\/j.gassur.2025.102275_bib21","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2011.36.0636","article-title":"Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma","volume":"29","author":"Kaseb","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5-6","key":"10.1016\/j.gassur.2025.102275_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000329040","article-title":"I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score","volume":"80","author":"Kaseb","year":"2011","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.gassur.2025.102275_bib23","doi-asserted-by":"crossref","first-page":"dju088","DOI":"10.1093\/jnci\/dju088","article-title":"Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma","volume":"106","author":"Kaseb","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gassur.2025.102275_bib24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2147\/JHC.S369951","article-title":"Serum IGF-1 scores and clinical outcomes in the phase III IMbrave150 study of atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma","volume":"9","author":"Kaseb","year":"2022","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"10.1016\/j.gassur.2025.102275_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","article-title":"The Brisbane 2000 terminology of liver anatomy and resections","volume":"2","author":"Strasberg","year":"2000","journal-title":"HPB"},{"issue":"12","key":"10.1016\/j.gassur.2025.102275_bib26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1159\/000502482","article-title":"Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients","volume":"98","author":"Abdel-Wahab","year":"2020","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.gassur.2025.102275_bib27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.18632\/oncotarget.27924","article-title":"Insulin-like growth factor 1\/Child-turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib","volume":"12","author":"Mohamed","year":"2021","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.gassur.2025.102275_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jir.2017.0107","article-title":"Preoperative serum insulin-like growth factor 1 level as a prognostic factor in patients undergoing hepatic resection for hepatocellular carcinoma","volume":"38","author":"Shen","year":"2018","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"10.1016\/j.gassur.2025.102275_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/lt.20111","article-title":"Growth hormone\/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study","volume":"10","author":"Bassanello","year":"2004","journal-title":"Liver Transpl"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25003348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25003348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:56:25Z","timestamp":1773802585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X25003348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1091255X25003348"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102275","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Surgery of the Alimentary Tract.","name":"copyright","label":"Copyright"}],"article-number":"102275"}}